Galectin-3 belongs to the galectin family, which is defined by conserved peptide sequence elements in the carbohydrate recognition domain (CRD), consisting of ~130 amino acid. Up to fourteen galectins (galectin-1~14) have been found in mammals so far, as well as in many other phyla including birds, amphibians, fish, nematodes, drosophila, sponges and fungi. While all galectins share a core sequence in their CRD, galectins exhibit interesting structural differences in the presentation of their CRD. Some galectins contain one CRD (prototype), and exist as monomers (galectin-5, 7, 10) or dimers (galectin-1, 2, 11, 13, 14) while other galectins, such as galectin-4, 6, 8, 9, 12 contain two CRD connected by a short linker region (tandem repeat) 1). In contrast, galectin-3 uniquely occurs as a chimeric protein with one CRD and an additional non-CRD domain, which is involved in its oligomerization. Upon binding to its glycan ligands at the cell surface, the conformation of galectin-3 appears to be altered, and galectin-3 oligomerizes by self-assembly of its N-terminal regulatory domain. This oligomerization results in the formation of galectin-3 molecules with multivalent CRDs 2). |
Category | Sugar binding proteins |
Protocol Name | Purification of recombinant human galectin-3(Gal-3) |
Authors
|
Milot, Valérie
Glycobiology and Bioimaging laboratory, Research Centre for Infectious Diseases, CHUQ, Laval University, Quebec
St-Pierre, Guillaume
Glycobiology and Bioimaging laboratory, Research Centre for Infectious Diseases, CHUQ, Laval University, Quebec
Sato, Sachiko
*
Glycobiology and Bioimaging laboratory, Research Centre for Infectious Diseases, CHUQ, Laval University, Quebec
*To whom correspondence should be addressed.
|
Reagents
|
● |
|
● |
BL21(DE3) E. coli strain transformed with expression plasmid for hGal-3 inducible by IPTG |
● |
Ampicillin (Sigma-Aldrich, St. Louis, MO: Cat. #A9518-25G) |
● |
IPTG (Roche cat #: 11 411 446 001) |
● |
Column buffer (50mM Tris-HCl pH 7.2, 105mM NaCl) |
● |
Elution buffer (150mM alpha-Lactose (Sigma-Aldrich: Cat. #L3635) in PBS(-) 1X) |
● |
Resuspension buffer (22mM Tris-HCl pH 7.5, 5mM EDTA 500), 1mM DTT (Thermo Fisher Scientific Inc., Waltham, MA: Cat. #20290) *prepare fresh |
● |
Protease inhibitor cocktail (Sigma-Aldrich: Cat. #P8465) |
● |
|
● |
Soduim azide 0,2% solution |
● |
α-Lactose Agarose column (Sigma-Aldrich Cat. #L7634-5mL) |
● |
ActiClean Etox column (Sterogene Bioseparations, Inc., Carlsbad, CA: Cat. #2705). (Preparation and use as proposed by the company: column is stored at 4°C in a 0.2% sodium azide solution. Before use, first drain completely the column. Then the column is washed with 5 column volumes of 1M NaOH followed by extensive wash with double distilled water until pH of the eluate becomes neutral. Then the column is equilibrated with 5 volumes of PBS(-) 1X. The column is then ready for use to purify protein. The column has to be washed immediately after each use with the same way (washed with NaOH, and water). If the column has been stored for more than a month, it should first be washed with 10 volumes of 5% acetic acid followed by the procedure described above.) |
|
Instruments
|
● |
Ultracentrifuge (Beckman L8-80M with rotor T70.1: Beckman Coulter, Inc., Brea, CA) |
● |
Centrifuge (Beckman Avanti J-20 XPI with rotor JLA 8.1000) |
● |
PD10 column (Amersham Pharmacia Biotech Inc., Piscatawaym NJ: Cat. #17-5087-01) |
● |
Pump related to the PD10 controlling the elution’s debit |
● |
Sonic Dismenbrator (Fisher Scientific Model 500) |
● |
Bacteria shaking incubator |
|
Methods |
1. |
Purification of recombinant human galectin-3 (Gal-3)
|
1) |
Inoculate 3 litters of LB-Ampicillin with BL21(DE3)-hGal-3 3)–6). |
Comment 0
|
|
2) |
Incubate overnight with agitation 225 rpm at 37°C (OD at 600nm reach to 0.7 to 1.2). |
Comment 0
|
|
3) |
Add IPTG at final concentration 1 mM and incubate 3 h at 37°C. |
Comment 0
|
|
4) |
Spin at 5,500 rpm for 20 min.
--Following steps should be done in ice or at 4°C— |
Comment 0
|
|
5) |
Discard the supernatant (remove the supernatant as much as possible by good draining). |
Comment 0
|
|
6) |
Resuspend the pellet (10 mL for each 1 L bacteria culture) with ice cold buffer (22 mM Tris-HCl (pH 7.5)-5 mM EDTA-1 mM DTT). |
Comment 0
|
|
7) |
Immediately add protease inhibitor cocktail 150 μL / 30 mL suspension. |
Comment 0
|
|
8) |
Begin prewash lactosyl column (5 mL) with 100 mL of column buffer (50 mM Tris-HCl pH 7.2, 105 mM NaCl). |
Comment 0
|
|
9) |
(Important—on ice) Sonicate the cell suspension at 120W for 30 sec (1 min interval between sonication) on ice for 8 times. |
Comment 0
|
|
10) |
Spin at 35,000 rpm for 30 min at 4°C using the rotor T70.1 in ultracentrifuge. |
Comment 0
|
|
11) |
Apply the supernatant to the prewashed α-Lactose agarose column. |
Comment 0
|
|
12) |
Wash column with 10 volumes (50 mL) of column buffer. |
Comment 0
|
|
13) |
Elute Gal-3 with 7 mL 150 mM lactose-column elution buffer.
- First close the cap and add 3 mL lactose buffer and rotate for 15 min, then collect the elution buffer in 1mL fraction.
- Then apply remaining 4 mL elution buffer to the column and continue to collect fractions.
- Identify the fractions containing Gal-3 by using Bradford protein assay, then pool positive fractions.
|
Comment 0
|
|
14) |
Pass Gal-3 on Hiprep desalting PD10 column using PBS(-) 1X as a buffer.
- Collect 1mL fractions Gal-3-positive fractions are between fractions 8–20.
- Identify the fraction containing Gal-3 by using Bradford protein assay then pool positive fractions.
- Be careful: if you extensively pool Gal-3 fractions, especially try to include fractions close to the fractions of salt elution, you might as well find some lactose in the pooled ones which reduces its lectin activity.
|
Comment 0
|
|
15) |
Concentrate on Amicon Centricon Plus-20 (10,000 MWCO), if necessary. |
Comment 0
|
|
16) |
Pass Gal-3 through acticlean EtOX column as many times as necessary to achieve endotoxin level less than 10 EU/mg (see step 21 for more explanation about endotoxin contamination). |
Comment 0
|
|
17) |
Filter sterile Gal-3 with Millex GV (Millipore Cat. #SLGV033RS). |
Comment 0
|
|
18) |
Determine the protein concentration with Bradford. |
Comment 0
|
|
19) |
(Quality control –SDS-PAGE) The purity of Gal-3 can be estimated by using a 12% SDS-polyacrylamide gel electrophoresis with ~10 μg of protein. The molecular weight of Gal-3 is approximately 30 kDa. |
Comment 0
|
|
20) |
(Quality control-hemagglytination assay) To estimate the activity of purified Gal-3 as a lectin, hemagglutination assay has to be routinely perform before its use (see methods in this website as well). |
Comment 0
|
|
21) |
(Quality control-endotoxin contamination) Endotoxin contamination should also be routinely checked by LAL assay. It should be less than 10 EU/mg with LAL kit from Lonza. We have tried both Lonza and Associated of Cap Code LAL kits (in case of false positives caused by a possible β-glucan contamination) and we obtained the same results for contamination level. |
Comment 0
|
|
22) |
Gal-3 should be kept in principal at 4°C. Gal-3 tends to become cleaved with time and loses its activity. Prior to use, check the activity with hemagglutination assay and cleavage level with a SDS-PAGE when use after 2 weeks kept at 4°C. |
Comment 0
|
|
23) |
Please note that unlike galectin-1, Gal-3 is stable in the absence of any reducing agents. Since some commercially available galectins contain significantly high concentration of reducing agents, such as DTT or mercaptoethanol, special caution should be paid when such reagents are used for biological assays. |
Comment 0
|
|
24) |
(Control-lectin activity) It is important to verify if the observed biological effect by Gal-3 is really due to its lectin activity. The lectin activity of galectins can be readily inhibited by β-galactoside-containing sugars, such as lactose (Galactoseβ1-4glucose) or other appropriate β-galactoside-containing oligosaccharides.
- Lactose is one of the most used inhibitors for galectins. In our laboratory, 50–150 mM lactose is routinely used to inhibit its lectin activity.
- When high concentrations of saccharide are used for cell assays, reduce salt (NaCl) concentration to achieve appropriate isotonicity (i.e., 317 mOsm/L) of the medium since cells exposed to hypertonic solutions would become fragile to any successive treatment.
|
Comment 0
|
|
|
Copyrights |
Attribution-Non-Commercial Share Alike
This work is released underCreative Commons licenses
|
Date of registration:2014-07-31 09:37:07 |
- Hirabayashi, J., and Kasai, K. (1993) The family of metazoan metal-independent beta-galactosidebinding lectins: structure, function and molecular evolution. Glycobiology 3, 297–304 [PMID : 8400545]
- Sato, S., St-Pierre, C., Bhaumik, P., and Nieminen, J. (2009) Galectins in innate immunity: dual functions of host soluble β-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunological Reviews. 30, 172–87 [PMID : 19594636]
- Nieminen, J., Kuno, A., Hirabayashi, J., and Sato, S. (2007) Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fluorescence resonance energy transfer. J Biol Chem. 282, 1374–83 [PMID : 17082191]
- Sato, S., Ouellet, N., Pelletier, I., Simard, M., Rancourt A., and Bergeron M.G. (2002) Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia. J Immunol. 168, 1813–22 [PMID : 11823514]
- Nieminen, J., St-Pierre, C., and Sato, S. (2005) Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses. J Leukoc Biol. 78, 1127–35 [PMID : 16260586]
- Nieminen, J., St-Pierre, C., Bhaumik, P., Poirier, F., and Sato, S. (2008) Role of galectin-3 in leukocyte recruitment in a murine model of lung infection by Streptococcus pneumoniae. J Immunol. 180, 2466–73 [PMID : 18250456]
|
This work is licensed under Creative Commons Attribution-Non-Commercial Share Alike. Please include the following citation
How to Cite this Work in an article:
Milot, Valérie,
St-Pierre, Guillaume,
Sato, Sachiko,
(2014). GlycoPOD https://jcggdb.jp/GlycoPOD.
Web.26,4,2024 .
How to Cite this Work in Website:
Milot, Valérie,
St-Pierre, Guillaume,
Sato, Sachiko,
(2014).
Purification of recombinant human galectin-3(Gal-3).
Retrieved 26,4,2024 ,
from https://jcggdb.jp/GlycoPOD/protocolShow.action?nodeId=t134.
html source
Milot, Valérie,
St-Pierre, Guillaume,
Sato, Sachiko,
(2014).
<b>Purification of recombinant human galectin-3(Gal-3)</b>.
Retrieved 4 26,2024 ,
from <a href="https://jcggdb.jp/GlycoPOD/protocolShow.action?nodeId=t134" target="_blank">https://jcggdb.jp/GlycoPOD/protocolShow.action?nodeId=t134</a>.
Including references that appeared in the References tab in your work is
much appreciated.
For those who wish to reuse the figures/tables, please contact JCGGDB
management office (jcggdb-ml@aist.go.jp).
|
|